Enliven Therapeutics, Inc. · NASDAQ:ELVN

Commodore Capital LP reported a 7.70% stake in Enliven Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Commodore Capital LP reported a 7.70% stake in Enliven Therapeutics, Inc., 4,800,940 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
7.70%
Shares
4,800,940
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP7.70%4,800,940
Commodore Capital Master LP7.70%4,800,940
Robert Egen Atkinson7.70%4,800,940
Michael Kramarz7.70%4,800,940

Source

View original at SEC

Related